DevaCell has a total of 10 patents globally, out of which 3 have been granted. Of these 10 patents, more than 50% patents are active. The USA & Europe (EPO) is where DevaCell has filed the maximum number of patents. Parallelly, the United States seems to be the main focused R&D center of DevaCell and is also the origin country of the firm.
DevaCell was founded in the year 2015. Company is a biotechnology firm that offers therapeutic indications.
Do read about some of the most popular patents of DevaCell which have been covered by us in this article and also you can find DevaCell patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over DevaCell patent portfolio.
How many patents does DevaCell have?
DevaCell has a total of 10 patents globally. These patents belong to 2 unique patent families. Out of 10 patents, 5 patents are active.
How Many Patents did DevaCell File Every Year?
The company has 10 patents and correspondingly the filing year is 2014 and 2021.
| Year of Patents Filing or Grant | DevaCell Applications Filed | DevaCell Patents Granted |
| 2022 | – | – |
| 2021 | 5 | – |
| 2020 | – | 2 |
| 2019 | – | 1 |
| 2018 | – | – |
| 2017 | – | – |
| 2016 | – | – |
| 2015 | – | – |
| 2014 | 5 | – |
How many DevaCell patents are Alive/Dead?
Worldwide Patents
How Many Patents did DevaCell File in Different Countries?
Countries in which DevaCell Filed Patents
| Country | Patents |
| United States Of America | 2 |
| Europe | 2 |
| Austria | 1 |
| Germany | 1 |
Where are Research Centres of DevaCell Patents Located?
The R&D Centre of patents filed by DevaCell is in the US.
List of DevaCell Patents
| DevaCell Patents | Title |
| US10300152B2 | Enzyme-Encapsulated Nanoparticle Platform |
| US20230272420A1 | Recombinant Viruses, Surface-Engineered Delivery Systems And Related Methods |
| EP3046550B1 | Enzyme-Encapsulated Nanoparticle Platform |
| EP4161545A2 | Recombinant Viruses, Surface-Engineered Delivery Systems And Related Methods |
| DE602014063899T2 | Enzyme Encapsulated Nanoparticle Platform |
| WO2022109503A1 | Recombinant Oncolytic Viruses, Surface-Engineered Delivery Systems And Related Methods |
| WO2022076756A1 | Recombinant Viruses, Surface-Engineered Delivery Systems And Related Methods |
| WO2021248080A3 | Recombinant Viruses, Surface-Engineered Delivery Systems And Related Methods |
| WO2015042204A1 | Enzyme-Encapsulated Nanoparticle Platform |
| AT1256466T | Enzyme Encapsulated Nanoparticle Platform |
What are DevaCell’s key innovation segments?
What Technologies are Covered by DevaCell?
The chart below distributes patents filed by DevaCell